肿瘤创新（英文）（Cancer Innovation） 知网目次维普目次

期刊简介

《肿瘤创新（英文）（Cancer Innovation）》期刊已被查看： 次

更新频次

单位占比

一作占比

投稿指南

1、投稿方式：在线投稿。

2、官网网址：

https://onlinelibrary.wiley.com/journal/27709183

3、投稿系统：

https://mc.manuscriptcentral.com/cancerinnovation

4、出刊日期：双月刊，逢双月出版。

2024年2月25日星期日

《肿瘤创新（英文）》（Cancer Innovation）简介

【微信公众号“水木医声”信息】

Cancer Innovation 是由教育部主管、清华大学主办，清华大学出版社出版的一本肿瘤领域的开放获取英文期刊。本刊由国家癌症中心的教育部“长江学者奖励计划”特聘教授——马飞担任主编。本刊关注肿瘤发生发展，肿瘤预防、精准诊疗过程中的基础科学、临床研究及转化应用等，旨在为肿瘤学相关研究人员提供权威的参考资料及最佳信息，推动肿瘤学领域发展，指导创新与医疗转变。

本刊依托清华大学及国家癌症中心的强大学术背景，领域涵盖肿瘤研究各方面的关键主题，聚焦于肿瘤新兴交叉学科、战略前沿及关键共性技术。致力于发表基础研究和临床肿瘤学领域创新且具有重大意义的研究成果，包括但不限于以下几点：

1. 新型抗肿瘤药物；

2. 有遗传/分子特征数据的临床试验；

3. 大数据驱动的肿瘤智能诊疗研究；

4. 肿瘤研究和工学、信息学、药学、生物学的多学科交叉肿瘤创新研究与临床转化；

5. 肿瘤学与其他医学亚专科，如心脏病学、神经病学、呼吸病学、生育学等跨学科融合研究及共病管理；

6. 肿瘤预防、诊断、治疗与管理的新观点、新理念、新方法、新模式。

本刊主要栏目包括：论著、临床指南、综述、述评、社论、技术报告、评论文章、观点及新闻报道等。

《肿瘤创新（英文）》（Cancer Innovation）作者指南

【官网信息】

Author Guidelines

Thank you for your interest in Cancer Innovation. Please refer to the following instructions to help you prepare your manuscript, and feel free to contact us if any questions. To ensure fast peer review and publication, manuscripts that do not adhere to the following instructions may be returned to the corresponding author for technical revision before undergoing peer review. We are looking forward to your submission.

Aims and scope

Cancer Innovation is a high-quality peer-reviewed open access journal covering key topics in all aspects of cancer research, focusing on emerging interdisciplinary, strategic frontiers and key common technologies in oncology. The journal is dedicated to publishing innovative and significant research results in basic research and clinical oncology, including novel antitumor drugs, especially clinical trials with genetic/molecular signature data, big data-driven research on intelligent tumor diagnosis and treatment, interdisciplinary oncology innovation research and clinical translation in engineering, informatics, pharmacology, and biology. It also includes multidisciplinary oncology research and clinical translation of oncology and other medical subspecialties, such as cardiology, neurology, respiratory medicine, fertility and other interdisciplinary integration research and co-morbidity management, and also new viewpoints, new ideas, new methods and new models of cancer prevention, diagnosis, treatment and management.

The journal focuses on the development of carcinogenesis, basic science, clinical research, and translational applications in tumor prevention and precision diagnosis and treatment, aiming to provide authoritative references and best information for oncology-related researchers, promote the development of the field of oncology, and guide innovation and medical transformation. We sincerely welcome and accept insights and discussions from oncology scholars and experts worldwide.

Submission and Peer Review Process

Once the submission materials have been prepared in accordance with the Author Guidelines, manuscripts should be submitted online at https://mc.manuscriptcentral.com/cancerinnovation

For help with submissions, please contact: cancerinnovation@tup.tsinghua.edu.cn

This journal does not charge submission fees.

……

更多详情：

https://onlinelibrary.wiley.com/page/journal/27709183/homepage/author-guidelines